In addition, the cytoskeleton distribution of SSc fibroblasts was affected by the three types of SOCE inhibitors; the cytoskeleton, as well as the fibrosis markers vimentin, α-SMA and fibronectin, was rearranged and even decreased in response to treatment with SOCE inhibitors (Fig 4D). The gene discussed is VIM; the disease is systemic sclerosis.